SAT0408 Long-Term Safety and Tolerability of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Safety Analysis of Three Phase 3, Randomized, Controlled Trials

Philip J. Mease, Arthur Kavanaugh, Dafna D. Gladman, Ade Adebajo, Juan J. Gómez‐Reino, J. Wollenhaupt, Maurizio Cutolo, Georg Schett, Éric Lespessailles, K. Shah,

Annals of the Rheumatic Diseases · 2014 · 17 citations · 0 references

Concepts